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Bacterial superantigens (SAg) are exotoxins from pathogens which interact with
innate and adaptive immune cells. The paradox that SAgs cause activation and
inactivation/anergy of T-cells was soon recognized. The structural and molecular events
following SAg binding to antigen presenting cells (APCs) followed by crosslinking of T-cell
receptors were characterized in detail. Activation, cytokine burst and T-cell anergy have
been described in vitro and in vivo. Later it became clear that SAg-induced T-cell anergy
is in part caused by SAg-dependent activation of T-regulatory cells (Tregs). Although the
main focus of analyses was laid on T-cells, it was also shown that SAg binding to MHC
class II molecules on APCs induces a signal, which leads to activation and secretion
of pro-inflammatory cytokines. Accordingly APCs are mandatory for T-cell activation.
So far it is not known, whether APCs play a role during SAg-triggered activation of
Tregs. We therefore tested whether in SAg (Streptococcal pyrogenic exotoxin A) -treated
APCs an anti-inflammatory program is triggered in addition. We show here that not
only the anti-inflammatory cytokine IL-10 and the co-inhibitory surface molecule PD-
L1 (CD274) but also inhibitory effector systems like indoleamine 2,3-dioxygenase (IDO)
or intracellular negative feedback loops (suppressor of cytokine signaling molecules,
SOCS) are induced by SAgs. Moreover, cyclosporine A completely prevented induction
of this program. We therefore propose that APCs triggered by SAgs play a key role in
T-cell activation as well as inactivation and induction of Treg cells.
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INTRODUCTION
Superantigens (SAg) are bacterial exotoxins which share unique immunological properties. SAg
released by staphylococci or streptococci during infection or even colonization induce a strong
activation of the immune system. Major hallmark of this activation is the fulminant release of
cytokines (Carlsson and Sjögren, 1985) leading to a disastrous cytokine storm (Miethke et al., 1992;
Michie et al., 1994) which might lead to an uncontrolled systemic shock with high lethality. The
toxic shock syndrome (TSS) was recognized to be mediated by a SAg, the TSS toxin 1, TSST-1
(Miethke et al., 1993). In the meantime, many bacterial exotoxins have been classiﬁed as SAgs
(Fraser and Proft, 2008), including the erythrogenic toxins of Streptococcus pyogenes (SPEA, SPEC)
and the enterotoxins from Staphlococcus aureus (Lina et al., 2004).
Superantigen behave like bifunctional agents: the bind to conserved regions of MHC class
II molecules and to V-beta encoded regions of the T-cell receptor (TCR) (Choi et al., 1990;
Dellabona et al., 1990). Crosslinking class II on APC with TCR induces T-cell activation with
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subsequent cytokine release. While all SAg bind to class II, the
binding to the TCR is V-beta speciﬁc, thus single SAg activates
a V-beta deﬁned subfraction of the T-cell pool (Kappler et al.,
1989). Nevertheless, in the human system a single SAg can
activate 1 to 10% of the T-cell pool, leading to a strong oligoclonal
T-cell response which exceeds the clone size activated by a protein
antigen at least by the factor of 1000 (Herrmann andMacDonald,
1991).
The tracking of SAg reactive T-cells using the V-beta TCR
expression has greatly facilitated the analyses of SAg-induced
T-cell responses. After initial activation accompanied with
secretion of cytokines including TNF, interleukin-2 (IL-2) and
IFN-gamma a phase of clonal T-cell expansion follows which is
then succeeded by apoptosis and clonal retraction (Herrmann
et al., 1992; Lee and Vitetta, 1992; Huang and Crispe, 1993;
Miethke et al., 1995). The apoptosis is not completely, roughly
50% of the initial numbers of V-beta bearing T-cells survive.
However, these T-cells fail to respond to further stimulation,
i.e., display an anergic phenotype (MacDonald et al., 1993; Wahl
et al., 1993). Unfolding of unresponsiveness is prevented in
the presence of the T-cell immunosupressive agent cyclosporine
A (CsA) but not rapamycin (Vanier and Prud’homme, 1992;
Prud’homme et al., 1995). This was taken as an indication that
anergy induction is dependent on calcineurin and is triggered
primarily in T-cells. Besides anergy induction it was also shown
TABLE 1 | Primers used.
Gene Forward – primer Reverse – primer
ß-Actin aga gct acg agc tgc ctg ac agc act gtg ttg gcg tac ag
calcineurin aaa cag tga ctg gcg cat c ccg gct tac agc aaa aga ag
IDO tta gag tca aat ccc tca gtc c ttt gca gat ggt agc tcc tc
IL-1b agc tga tgg ccc taa aca ga gca tct tcc tca gct tgt cc
IRF-1 gct ggg aca tca aca agg at tgg tct ttc acc tcc tcg at
JNK gca tgg gct aca agg aaa ac ttc agg aca tgg tgt tcc aa
p38 gac aca aaa acg ggg tta cg tgg gtc acc aga tac aca tca
p44/42 agt aca tcc act ccg cca ac cgt agc cac ata ctc cgt ca
CD274 tgc tgt ctt tat att cat gac cta c tcc tcc att tcc caa tag aca
SOCS1 tcc ccc tca acc ccg t cat ccg ctc cct cca acc
SOCS3 ggg agt ccc ccc aga aga g ata gga gtc cag gtg gcc gt
STAT1 ccg ttt tca tga cct cct gt ggc gtt ttc cag aat ttt cc
STAT3 cag gtt gct ggt caa att cc tgt gtt tgt gcc cag aat gt
TDO ggt tcc tca ggc tat cac tac c cag tgt cgg gga atc agg t
that after stimulation with SAg the fraction of CD4++CD25+
foxp3+ Treg within the T-cell pool is signiﬁcantly augmented
(Wang et al., 1998; Papiernik, 2001; Feunou et al., 2003;
Grundström et al., 2003; Ivars, 2007). The cellular interactions
and signaling pathways leading to Treg induction after SAg
stimulation are not well understood.
FIGURE 1 | Streptococcal pyrogenic exotoxin A (SPEA)- induced cytokines. CD14+ monocytes were stimulated with increasing concentrations of SPEA.
24 h after stimulation supernatants were analyzed by ELISA for (A) IL-6, (B) TNF, (C) IL-12p40 and (D) IL-10 (mean ± SD, n = 5). Statistical analysis was performed
using a Multiple Comparison of Means (Tukey Contrasts). Significance code: 0 ‘∗∗∗’; 0.001 ‘∗∗’; 0.01 ‘∗’.
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FIGURE 2 | Streptococcal pyrogenic exotoxin A- induced surface molecules. CD14+ monocytes were stimulated with increasing concentrations of SPEA as
indicated. 24 h after stimulation cells were harvested and analyzed for surface markers by flow cytometry (A) MHC-II, (B) CD80, (C) CD86 and (D) PD-L1. The mean
fluorescent intensity of three different experiments is shown. The line represents the mean of the experiments.
FIGURE 3 | Streptococcal pyrogenic exotoxin A- induced mRNA expression of inhibitory pathways. CD14+ monocytes were stimulated 24 h with
increasing concentrations of SPEA. Quantitative real-time PCR of cDNA was performed for (A) CD274, (B) Il1b, (C) IDO, (D) TDO, (E) SOCS1, and (F) SOCS3.
Shown is the mean of induction compared to ß-Actin (±SD) of 5 donors. Statistical analysis was performed using a Multiple Comparison of Means (Tukey Contrasts).
Significance code: 0 ‘∗∗∗’; 0.001 ‘∗∗’; 0.01 ‘∗ ’.
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FIGURE 4 | Signaling pathways involved in SPEA- mediated activation of APC. CD14+ monocytes were stimulated with SPEA (100ng/ml) in the presence or
absence of (A) VIVIT (1 M), (B) Wortmannin (50 nM), (C) rapamycin (50nM) and (D) piceatannol (50 μM) or DMSO (equal volume to inhibitor) as solvent control. 24 h
after stimulation supernatants were harvested and ELISAs were performed for IL-6, IL-10, IL-12p40 and TNF. Shown is the mean ±SD from 3 different donors,
except VIVIT (n = 2). Statistical analysis was performed using a Multiple Comparison of Means (Tukey Contrasts). Significance codes: 0 ‘∗∗∗’; 0.001 ‘∗∗’; 0.01 ‘∗’.
For T-cell activation, the presence of APC and the binding of
SAg to their MHC class II molecules are mandatory (MacDonald
et al., 1993; Rink et al., 1997). The binding regions of SAg to
MHC class II have been studied and characterized in detail. It
became evident that SAg not only binds to class II but also share
the ability at diﬀerent levels to crosslink MHC class II molecules
(Hudson et al., 1995; Kozono et al., 1995). This suggested that
SAg might confer a signal to the MHC class II expressing
APC. Indeed MHC class II signaling after crosslinking has been
observed in B-cells and stem cells which was characterized by
activation of tyrosine kinases like Syk (Mooney et al., 1990,
1994; Scholl and Geha, 1994; Kanner et al., 1995; Yamaguchi
et al., 1999). In monocytes binding of SAg and thus crosslinking
of MHC class II molecules was followed by an intracellular
increase of Ca2+ which was then succeeded by activation and
eventually secretion of pro-inﬂammatory cytokines like TNF
(Palkama and Hurme, 1993; Trede et al., 1993a,b; Mehindate
et al., 1995; Espel et al., 1996; Khan et al., 2008). Interestingly
Treg seem to utilize class II signaling too. Mature Tregs express
LAG-3 (CD223) which has been shown to bind to MHC class
II and to crosslink subsequently the molecules (Hemon et al.,
2011).
Since SAg-mediated stimulation of T-cells includes activation
as well as tolerization processes we hypothesized that both
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FIGURE 5 | Cyclosporine A (CsA) prevents secretion of cytokines. CD14+ monocytes were stimulated with SPEA (100 ng/ml) and CsA (1 μM) or Ethanol
(equal volume to CsA) for 24 h. Supernatants were harvested and analyzed by ELISA for (A) IL-6, (B) TNF, (C) IL-12p40 and (D) IL-10. Shown is the mean
concentration with standard deviation of 5 different donors. Significance codes: 0 ‘∗∗∗’; 0.001 ‘∗∗’; 0.01 ‘∗’ (Tukey Contrasts).
events are determined by respective cellular or humoral events
triggered in APC by SAg. We therefore tested whether co-
inhibitory molecules (such as PD-L1; Francisco et al., 2009,
2010), negative signaling circuits (such as suppressor of cytokine
signaling molecules, SOCS; Alexander, 2002; Strebovsky et al.,
2011), or inhibitory eﬀector systems (such as IDO; Lestage
et al., 2002; Hill et al., 2007) are induced by SAg in
APC.
MATERIALS AND METHODS
Reagents
Streptococcal pyrogenic exotoxin A (SPEA) was purchased from
Toxin Technology Inc. (Sarasota, FL, USA). ThemTOR–inhibitor
rapamycin (50 nM), NFAT–inhibitor VIVIT (1 M), PI3–kinase–
inhibitor Wortmannin (50 nM) and piceatannol (50 μM), a
Syk–inhibitor were acquired from Calbiochem (Schwalbach,
Germany). CsA was purchased from R&D Systems (Wiesbaden,
Germany).
Isolation of Primary Cells
Human peripheral blood mononuclear cells (PBMCs) were
isolated from fresh blood by density gradient centrifugation
(Pancoll 1.077 g/ml; PAN Biotech). Monocytes were isolated
via CD14 MicroBeads (Miltenyi Biotech, Bergisch-Gladbach,
Germany) with the autoMACS separator. 2 × 106 cells were
cultured in RPMI 1640 (Sigma–Aldrich, Taufkirchen, Germany)
supplemented with 100 IU/mL of penicillin, 100 μg/mL
streptomycin containing 10% heat inactivated fetal calf serum
(Promocell, Heidelberg, Germany) at 37◦C in a humidiﬁed
atmosphere in the presence of 5% CO2 and stimulated for
24 h.
Flow Cytometry
Twenty four hours after stimulation monocytes were analyzed
for the surface markers CD14 (clone TÜK4), CD80 (clone
L307.4), CD86 (clone IT2.2), PD-L1 (clone MIH1) and MHC-II
(clone Tu39). Analyses were performed on a FACS Canto I (BD
Biosciences).
The antibodies were purchased from Becton Dickinson
(Heidelberg, Germany), except PD-L1 (eBioscience,
Frankfurt/Main, Germany).
Western Blotting
8 × 106 cells were lysed 24 h after stimulation in RIPA
lysis buﬀer containing protease inhibitor cocktail and
phosphatase inhibitor cocktail from Roche (Mannheim,
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FIGURE 6 | Cyclosporine A prevents the expression of costimulatory and coinhibitory molecules. CD14+ monocytes were stimulated with SPEA
(100 ng/ml) and CsA (1 μM) or Ethanol (equal volume to CsA) for 24 h. Cells were harvested and analyzed for surface markers by flow cytometry (A) MHC-II,
(B) CD80, (C) CD86 and (D) PD-L1. The mean fluorescence intensity of three different donors is shown.
Germany). Equal amounts of the lysates were fractionated
by SDS-PAGE and electrotransferred to nitrocellulose
membranes. After blocking and washing steps the indicated
antibodies, purchased from Cell Signaling Technology
(Danvers, MA, USA), were incubated for 24 h and detected
via chemiluminescence (ECL; Perkin Elmer, Groningen,
Netherlands).
ELISA
Cell-free supernatants were harvested 24 h after stimulation and
analyzed for IL–6, IL–10, IL–12p40 and TNF by commercial
available ELISA kits from Becton Dickinson (OptEIA;
Becton Dickinson, Heidelberg, Germany) according to the
manufacturer’s instructions.
Statistics
Statistical signiﬁcance was assessed using SPSS statistics software
and paired student’s t-test evaluation with ∗: p ≤ 0.05, ∗∗:
p ≤ 0.005. Further on we conﬁrmed the results with Multiple
Comparisons of Means (Tukey Contrasts), performed with R.
Signiﬁcance codes: 0 ‘∗∗∗’ 0.001 ‘∗∗’ 0.01 ‘∗’ 0.05 ‘.’ 0.1 ‘ ’ 1. When
the results of the methods diﬀer, signiﬁcance of Tukey’s test is
shown.
RNA Purification and Quantitative Real –
Time PCR
Total RNA from 4 × 106 cells was isolated using the High
Pure RNA isolation Kit (Roche, Mannheim, Germany), cDNA
was synthesized from equal amounts of RNA using the ﬁrst
strand cDNA kit from Thermo Scientiﬁc (Waltham, MA
USA). Quantitative real–time RT-PCR was performed using
ABsoluteTM QPCR SYBRR©Green Low ROX Mix (Thermo
Scientiﬁc, Waltham, MA, USA). Relative expression was
calculated by normalization to β–Actin mRNA expression levels
as 2-Ct. All primers were synthesized by Euroﬁns MWG
Operon (Ebersberg, Germany) (Table 1).
RESULTS
Superantigens Induce Cytokine
Secretion in APC
It has been shown previously that binding of SAg to MHC
class II molecules induces activation and secretion of cytokines.
When we incubated monocytes for 24 h with graded doses of
SPEA a dose dependent induction of cytokine secretion was
found (Figures 1A–C). Not only pro-inﬂammatory cytokines
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FIGURE 7 | Cyclosporine A – mediated expression of mRNA. CD14+ monocytes were stimulated 24 h with SPEA (100 ng/ml) and CsA (1 μM) or Ethanol
(equal volume to CsA). Quantitative real-time PCR of cDNA was performed with sequence-specific primers for (A) CD274, (B) Il1b, (C) IDO, (D) TDO. Data were
normalized to ß-Actin. Shown is the mean and standard deviation of 5 donors. Statistical analysis was performed using a Multiple Comparison of Means (Tukey
Contrasts). Significance codes: 0 ‘∗∗∗’; 0.001 ‘∗∗ ’; 0.01 ‘∗’.
like IL-6, TNF, or IL-12p40 were induced but also secretion of
anti-inﬂammatory IL-10 could be recorded (Figure 1D).
Next we assayed for the expression of surface molecules
involved in antigen presentation and T-cell interaction
(Figure 2). The surface expression of MHC class II molecules
showed no dependency on SPEA stimulation (Figure 2A), while
a dose-dependent expression of the co-stimulatory molecules
CD80 and CD86 was observed (Figures 2B,C). Interestingly the
co-inhibitory molecule PD-L1 (CD274) was strongly induced
(Figure 2D, Supplementary Figure S1).
Superantigens Induce mRNA Expression
of Inhibitory Pathways
Since PD-L1 expression indicated that inhibitory pathways might
be induced we analyzed the mRNA expression of molecules
involved in negative regulatory circuits (Figure 3). As expected
mRNA expression of PD-L1 was signiﬁcantly enhanced after
treatment with SPEA (Figure 3A). The same was true for IL-
1beta (Figure 3B). As IL-1 beta is produced as inactive precursor
we additionally conﬁrmed the elevated release of the active
cytokine (Supplementary Figure S2). Surprisingly expression of
the inhibitory eﬀector enzyme IDO was observed (Figure 3C).
In contrast, expression of tryptophan 2,3-dioxygenase (TDO)
FIGURE 8 | Indoleamine 2,3-dioxygenase expression after SPEA
stimulation. CD14+ monocytes were stimulated for 1 h or 24 h with
100 ng/ml SPEA and 1 μM CsA (Ethanol was used equal to the amount of
CsA). Cells were lysed and analyzed by western blot for IDO. ß-Actin as
loading control was displayed. Shown is one representative experiment out of
three.
was suppressed (Figure 3D) suggesting an inverse regulation.
Within APCs negative feedback loops have been identiﬁed which
regulate the response to cytokine stimulation. Molecules of the
SOCS family play a pivotal role during these processes. We
therefore analyzed the expression of SOCS1 and SOCS3 after
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FIGURE 9 | STAT activation after SPEA stimulation. (A) CD14+
monocytes were stimulated for 1 or 24 h with 100 ng/ml SPEA and 1 μM CsA
(Ethanol was used equal to the amount of CsA). Cells were lysed and
analyzed by western blotting with specific antibodies against STAT1,
phospho-STAT1 (Ser727, Tyr701), STAT3, phospho-STAT3 (Ser727, Tyr 705),
STAT5 and phospho-STAT5 (Tyr 694). GAPDH as loading control was
displayed. Shown is one representative experiment out of three.
stimulation of monocytes with SAg. While SOCS1 showed a
clear induction, SOCS3 was only slightly induced (Figures 3E,F).
mRNA expression of other signaling molecules was unchanged
except for STAT1 and IRF-1which showed a slight increased
expression (Supplementary Figure S3).
Signaling Pathways Involved in
SAg-Mediated Activation of APC
It was suggested that class II-signaling induces Ca-mobilization
(Mooney et al., 1990) and subsequent activation. SAg-mediated
signaling in APC could thus be mediated by non-classical
signaling pathways. Besides NFAT-dependent or Syk-dependent
pathways which have been shown in B-cells (Scholl et al., 1992;
Palkama andHurme, 1993; Morio et al., 1994; Haylett et al., 2009)
other non-canonical pathways (mTOR, PI3K) could mediate
SAg stimulation of APC. To test this, we resorted to classical
inhibition assays (Figure 4). When we tested for inhibition of the
induction of pro-inﬂammatory and anti-inﬂammatory cytokines
we failed to observe an eﬀect with the inhibitors of NFAT (VIVIT)
(Figure 4A) and PI3K (Wortmannin) (Figure 4B). Inhibition of
mTOR pathway by rapamycin or Syk pathway by piceatannol had
no eﬀect on the induction of pro-inﬂammatory cytokines (TNF,
IL-6, IL-12), however, rapamycin and piceatannol prevented
release of IL-10 indicating a diﬀerential regulation of pro- and
anti-inﬂammatory cytokines (Figures 4C,D).
Cyclosporine A interacts with cyclophilin and suppresses
activation of T-cells and B-cells (Fischer et al., 1989). We
thus hypothesized that CsA could interfere with SAg-mediated
stimulation of APC. Indeed stimulation of monocytes with
SPEA in the presence of CsA prevented the secretion of
pro-inﬂammatory and anti-inﬂammatory cytokines signiﬁcantly
(Figure 5). Further on CsA modulated the SPEA-induced
expression of co-stimulatory and co-inhibitory molecules,
although not in a statistically signiﬁcant mode (Figure 6).
A similar pattern was observed for the induction of mRNA:
CsA prevented the upregulation of mRNA coding for PD-
L1 (Figure 7A), IL-1beta (Figure 7B), and partially reduced
induction of IDO (Figure 7C). Accordingly, expression of TDO
was not downregulated (Figure 7D).
Indoleamine 2,3-dioxygenase is a rate-limiting enzyme of
tryptophan catabolism resulting in kynurenine production.
Depletion of tryptophan causes halted growth of T-cells while
kynurenine activates the aryl hydrocarbon (AH) receptor system
leading to induction of Tregs (Opitz et al., 2011). We therefore
tested for the expression of IDO and the subsequent depletion of
tryptophan and production of kynurenine after SAg stimulation
(Figure 8). In SPEA-stimulated APC IDO protein expression was
detected (Figure 8) and the levels of kynurenine were enhanced
(data not shown). Both IDO expression and kynurenine
production was sensitive to inhibition by CsA corroborating the
eﬀects seen with mRNA induction (Figure 7C).
STAT Activation is a Hallmark of
SAg-Mediated Stimulation of APCs
To further elucidate the signaling pathways in SAg-mediated
stimulation of APC we analyzed the phosphorylation pattern
of STAT molecules and MAPK after stimulation. While
phosphorylation of MAPK (p38, JNK, P44/42) was not changed
(Supplementary Figure S4), STAT1 and STAT3 were immediately
phosphorylated, independent on CsA (Figure 9). STAT5 showed
no phosphorylation. In contrast, after 24 h STAT1, STAT3,
and STAT5 were strongly phosphorylated (Figure 9). The
phosphorylation observed was sensitive to inhibition by CsA.
DISCUSSION
Superantigens are bacterial exotoxins that interact with immune
cells. It was recognized long ago that activation as well as
inactivation/tolerance of T-cells represent an obvious paradox.
However, both reaction proﬁles might contribute to the immune
evasion strategy of the pathogens (MacDonald et al., 1993). It is
unquestionable that acute release of pro-inﬂammatory cytokines
leads to a dysregulation of the immune and other systemic
responses eventually causing septic shock. Staphylococcal or
streptococcal TSS are examples of this pathogenesis (Miethke
et al., 1993). They resemble cytokine storm events comparable
to those observed in humans after accidentally triggering T-cells
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with monoclonal antibodies (Suntharalingam et al., 2006). The
induction of T-cells requires binding of SAg to MHC class II
molecules of APC and the followed crosslinking of T-cells to
APCs (Rink et al., 1997). Binding of SAg activates APC, resulting
in production of co-stimulatory cytokines and co-stimulatory
molecules (Ohnishi et al., 1995).
Concomitantly inhibitory circuits are induced that
subsequently dominate. After initial deletion of SAg-reactive
T-cells the remaining T-cells become unresponsive and display
an anergic phenotype (Kisielow et al., 1991; Wahl et al., 1993).
Moreover it was shown that anergy and unresponsiveness are
accompanied by the induction of CD4+CD25+ T regulatory
cells (Wang et al., 1998; Noël et al., 2001; Papiernik, 2001). It is
quite obvious that cytokine storm, anergy and induction of Treg
induce a milieu of dysregulation and suppression that precludes
a coordinated immune response and thus allows the pathogen to
subvert anti-infective strategies of the host.
We show here that APC function after SAg-binding not
only includes the induction of pro-inﬂammatory responses
in terms of cytokine release and costimulation but also the
induction of co-inhibitory circuits including anti-inﬂammatory
cytokines (IL-10), co-inhibitory molecules (PD-L1) and also an
induction of inhibitory eﬀector programs (IDO). While IDO
might result in an unspeciﬁc immunosupression by depleting
tryptophan (Taylor and Feng, 1991) PD-L1 and IL-10 suggest
an at least bystanding activity to induce Tregs (Unger et al.,
2009; Wölﬂe et al., 2011). Moreover kynurenine an intermediate
of the tryptophan metabolism produced by IDO, can further
screw T-cell diﬀerentiation in direction of Tregs (Quintana
et al., 2008; Gandhi et al., 2010; Opitz et al., 2011). Altogether
an immunosuppressive milieu is induced which clearly foster
the generation of Tregs and thus prevents an active immune
response. Indeed our experiments with SPEA-treated monocytes
conﬁrm their inhibitory inﬂuence on CD3-mediated T-cell
proliferation (Supplementary Figure S5). Furthermore SPEA-
treated co-culture experiments with APCs and T-cells reveal a
CD4+CD25+Foxp3+ Treg population (Supplementary Figure
S6) that is functionally active and inhibits T-cell proliferation
(Supplementary Figure S7).
Interestingly, negative feedback regulators for IFN signaling
(SOCS-1) were also induced by SPEA (Song and Shuai, 1998;
Dalpke et al., 2008; Masters et al., 2010). This could explain
why APCs are refractory to stimulation with proinﬂammatory
cytokines like IFN-gamma and thus maintain their inhibitory
phenotype. We also observed a long lasting phosphorylation
of STAT1 as well as STAT3 after SAg treatment of APC.
Phosphorylated STAT3 induce expression of PD-L1 (Wölﬂe
et al., 2011) and IDO (Litzenburger et al., 2014) and thus
contribute to the immunosuppressive milieu. Constitutive STAT1
phosphorylation seems to contradict the immunosuppressive
phenotype. Although we have not addressed this here in detail,
it was shown that STAT1 action itself is under control of
SOCS-1, which could explain why STAT1 phosphorylation does
not necessarily induce proinﬂammatory cascades (Hildebrand
et al., 2010).
A critical role during these processes of tolerance induction
plays the APC. APC represent the scaﬀold to present SAg to
T-cells (Dellabona et al., 1990), yet also provide other signals to
the T-cells (Mehindate et al., 1995). Therefore class II-binding of
SAg has to deliver a signal to the APC. Class II signaling has been
described for B-cells (Mooney et al., 1990; Nabavi et al., 1992)
and APCs (Chatila and Geha, 1993). Thereby diﬀerent signal
intermediates such as Ca2+ (Damaj et al., 1992), PKC (Palkama
and Hurme, 1993), NFAT and MAPK (Haylett et al., 2009), and
tyrosine kinases (Palkama and Hurme, 1993; Morio et al., 1994;
Kanner et al., 1995) were shown. When we analyzed SAg-induced
signaling using various inhibitors, we found no indication for
an involvement of PI3K (Wortmannin), mTOR (rapamycin) or
the tyrosine kinase Syk (piceatannol) (Figure 4). Since Ca2+
mobilization can be a consequence of SAg-activation (Damaj
et al., 1992) we presumed that NFAT would be involved, yet this
was not the case. In contrast all responses induced by SAg could
be blocked by CsA. This was not an entirely surprising ﬁnding
since we have reported recently that in an analogous stimulation
model in B-cells signaling was also sensitive to inhibition with
CsA but not dependent on NFAT (Ziegler et al., 2014). The
sensitivity to CsA of the induction of an immunosuppressive
milieu of APC ﬁts well in older reports on the unfolding
of tolerance and unresponsiveness. Sakaguchi reported that
neonatal administration of CsA induced autoimmune disease in a
model which was depended on Tregs (Sakaguchi and Sakaguchi,
1989). It was also shown that CsA inhibits Treg generation (Wang
et al., 2006) and that immunosuppressive therapy with CsAmight
reduce the number of Treg after allogeneic renal transplantation
(Korczak-Kowalska et al., 2007).
Cyclosporine A might interfere with the induction of Treg in
two ways. Once it inhibits the Treg inducing milieu after class
II binding of SAgs as described above. Secondly, CsA might
aﬀect the self-stabilizing feedback loop of Treg-APC interaction.
Tregs express LAG-3 which interacts with class II molecules
(Liang et al., 2008). Interaction could lead to APC activation and
subsequent production of inhibitory cytokines and molecules as
shown above. That would lead to a self-propagation of Tregs
and thus stabilize and expand the Treg pool. Accordingly CsA
would prevent this loop by inhibiting the response to class II
crosslinking. It has been shown that blockade of PD-L1 and LAG-
3 rapidly cleared infection with plasmodia (Butler et al., 2012),
indicating that during infection this loop is operative and could
be manipulated.
Taken together we show here that APC triggered by SAg
are not only responsible for the initial induction of pro-
inﬂammatory responses but are also crucial for the induction and
maintenance of unresponsiveness and anergy. Paradoxically the
T-cell immunosuppressive drug CsA prevents in SAg triggered
APC the manifestation of the immunosuppressive program,
indicating that CsA could be utilized to prevent SAg-induced
anergy and unresponsiveness.
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